Pablo Ruiz-Flores

Dr. Pablo Ruiz-Flores

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Open access
PDF file
FMFermín Mar-Aguilar
Fermín Mar-Aguilar
JMJorge A Mendoza-Ramírez
Jorge A Mendoza-Ramírez
IMIsmael Malagón-Santiago
Ismael Malagón-Santiago
PEPerla K Espino-Silva
Perla K Espino-Silva
SSSandra K Santuario-Facio
Sandra K Santuario-Facio
DRDiana Reséndez-Pérez
Diana Reséndez-Pérez
MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules that can regulate gene expression, thereby affecting crucial processes in cancer development. miRNAs offer great potential as biomarkers for cancer detection because of their remarkable stability in blood and their characteristic expression in different diseases. We investigated whether quantitative RT-PCR miRNA profiling on serum could discriminate between breast cancer patients and healthy controls. We performed miRNA profiling on serum from breast cancer patients, followed by construction of ROC (Receiver Operating Characteristic) curves to determine the sensitivity and specificity of the assay. We found that seven miRNAs (miR-10b, miR-21, miR-125b, miR-145, miR-155 miR-191 and miR-382) had different expression patterns in serum of breast cancer patients compared to healthy controls. ROC curve analyses revealed that three serum miRNAs could be valuable biomarkers for distinguishing BC from normal controls. Additionally, a combination of ROC curve analyses of miR-145, miR-155 and miR-382 showed better sensitivity and specificity of our assay. miRNA profiling in serum has potential as a novel method for breast cancer detection in the Mexican population.

15 January 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DTDeborah Thompson
Deborah Thompson
CSCsilla I. Szabo
Csilla I. Szabo
JMJon Mangion
Jon Mangion
RORogier A. Oldenburg
Rogier A. Oldenburg
FOFabrice Odefrey
Fabrice Odefrey
MSMichael R. Stratton
Michael R. Stratton
The known susceptibility genes for breast cancer, including BRCA1 and BRCA2, only account for a minority of the familial aggregation of the disease. A recent study of 77 multiple case breast cancer families from Scandinavia found evidence of linkage between the disease and polymorphic markers on chromosome 13q21. We have evaluated the contribution of this candidate “BRCA3” locus to breast cancer susceptibility in 128 high-risk breast cancer families of Western European ancestry with no identified BRCA1 or BRCA2 mutations. No evidence of linkage was found. The estimated proportion (α) of families linked to a susceptibility locus at D13S1308, the location estimated by Kainu et al. [(2000) Proc. Natl. Acad. Sci. USA 97, 9603–9608], was 0 (upper 95% confidence limit 0.13). Adjustment for possible bias due to selection of families on the basis of linkage evidence at BRCA2 did not materially alter this result (α = 0, upper 95% confidence limit 0.18). The proportion of linked families reported by Kainu et al. (0.65) is excluded with a high degree of confidence in our dataset [heterogeneity logarithm of odds (HLOD) at α = 0.65 was −11.0]. We conclude that, if a susceptibility gene does exist at this locus, it can only account for a small proportion of non-BRCA1/2 families with multiple cases of early-onset breast cancer.

8 April 2011 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
RRRogelio Recio‐Vega
Rogelio Recio‐Vega
VVVictor Velazco‐Rodriguez
Victor Velazco‐Rodriguez
GOGuadalupe Ocampo‐Gómez
Guadalupe Ocampo‐Gómez
SHSandra Hernandez‐Gonzalez
Sandra Hernandez‐Gonzalez
PRPablo Ruiz-Flores
Pablo Ruiz-Flores
FLFrancisco Lopez‐Marquez
Francisco Lopez‐Marquez

1 July 2018 in DNA and Cell Biology
Verified
Journal Article
Closed access
JRJuan Ramos-Treviño
Juan Ramos-Treviño
SBSusana Bassol-Mayagoitia
Susana Bassol-Mayagoitia
JHJosé Anselmo Hernández-Ibarra
José Anselmo Hernández-Ibarra
PRPablo Ruiz-Flores
Pablo Ruiz-Flores
MNMartha P. Nava-Hernández
Martha P. Nava-Hernández
Over the past decades, an increase has been described in exposure to environmental toxins; consequently, a series of studies has been carried out with the aim of identifying problems associated with health. One of the main risk factors is exposure to heavy metals. The adverse effects that these compounds exert on health are quite complex and difficult to elucidate, in that they act at different levels and there are various signaling pathways that are implicated in the mechanisms of damage. The Sertoli cells plays a role of vital importance during the process of spermatogenesis, and it has been identified as one of the principal targets of heavy metals. In the present review, cadmium, lead, and arsenic are broached as altering the physiology of the Sertoli cells, citing mechanisms that have been cited in the literature.

1 April 2005 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
ACAna Laura Calderón-Garcidueñas
Ana Laura Calderón-Garcidueñas
PRPablo Ruiz-Flores
Pablo Ruiz-Flores
RCRicardo Cerda-Flores
Ricardo Cerda-Flores
HBHugo A Barrera-Saldaña
Hugo A Barrera-Saldaña
OBJECTIVE: This study describes the presence of mutations in BRCA1 and BRCA2 genes in a group of Mexican women and the clinical evolution of early onset breast cancer (EOBC). MATERIAL AND METHODS: A prospective hospital-based study was performed in a sample of 22 women with EOBC (7 in clinical stage IIA, 8 in IIB, and 7 in IIIA). The patients attended a tertiary care hospital in northeastern Mexico in 1997 and were followed up over a 5-year period. Molecular analysis included: 1) a mutation screening by heteroduplex analysis (HA) of BRCA1 and BRCA2 genes and 2) a sequence analysis. RESULTS: Of 22 patients, 14 (63.6%) showed a variant band detected by heteroduplex analysis of the BRCA1 and BRCA2 genes: 8 polymorphisms, 4 mutations of uncertain significance, and 2 novel truncated protein mutations, one in BRCA1 (exon 11, 3587delT) and the other in the BRCA2 gene (exon 11, 2664InsA). CONCLUSIONS: These findings support future studies to determine the significance and impact of the genetic factor in this Mexican women population.

1 October 2017 in DNA and Cell Biology
Verified
Journal Article
Closed access
JRJuan Ramos-Treviño
Juan Ramos-Treviño
SBSusana Bassol-Mayagoitia
Susana Bassol-Mayagoitia
PRPablo Ruiz-Flores
Pablo Ruiz-Flores
PEPerla Karina Espino-Silva
Perla Karina Espino-Silva
OSOdila Saucedo-Cárdenas
Odila Saucedo-Cárdenas
MNMartha P. Nava-Hernández
Martha P. Nava-Hernández
The Sertoli cell plays a vital role during the spermatogenesis process and has been identified as one of the main targets of the toxic action of heavy metals on the seminiferous epithelium. In the present work, the effect of lead (Pb), Arsenic (As), and Cadmium (Cd) in primary cultures of Sertoli cells was analyzed by measuring the expression of the genes Cldn11, Ocln, and Gja1 that participate in the tight and gap junctions, which are responsible for maintaining the blood–testis barrier. Sertoli cells were isolated from the testes of Wistar rats. Sertoli cell cultures were exposed separately and at the same concentrations of three heavy metals for 48 h. Subsequently, gene expression was measured by real-time polymerase chain reaction. In the morphological analysis of the cultures, after 24 h, the cultures exposed to Cd showed greatest detachment of the monolayer, followed by those exposed to As and Pb. As for gene expression patterns, As induced a decrease in the expression of the Cldn11 gene at 24 and 48 h (p < 0.01) and in that of Ocln at 24 (p < 0.001) and 48 h (p < 0.01), whereas Cd induced overexpression of the Gja1 gene from day 1 of exposure (p < 0.001) and subexpression of the Ocln gene (p < 0.05) at 24 h. Because each of these three metals generated different expression patterns in the three genes, we can postulate that the mechanisms of damage that they induce are different; therefore, the effect that they exert on the Sertoli cell occurs through different pathways, generating changes in structural proteins, altering Sertoli cell morphology, and compromising its function in the regulation of the spermatogenesis process.